Condition
Brain Computer Interface
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07333339Completed
A Brain-Computer Interface-Based Attention Training Program Compared With Methylphenidate and Citicoline
NCT05965713Not ApplicableCompleted
National Fully Remote Use of IpsiHand Device in Hemiparetic Stroke
NCT07147881Not Yet Recruiting
Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors
NCT05778448Not ApplicableCompleted
BCI for Hemiparetic Upper Extremities in Patients Due to Stroke
Showing all 4 trials